QLGN - Qualigen Therapeutics EPS misses by $0.61 misses on revenue November, 13 2020 09:09 AM Qualigen Therapeutics Inc. Qualigen Therapeutics (QLGN): FQ2 GAAP EPS of -$0.41 misses by $0.61.Revenue of $0.84M (-30.0% Y/Y) misses by $0.75M.Press Release For further details see: Qualigen Therapeutics EPS misses by $0.61, misses on revenue